A detailed history of Privium Fund Management B.V. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 286,936 shares of ARWR stock, worth $5.73 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
286,936
Previous 273,936 4.75%
Holding current value
$5.73 Million
Previous $7.83 Million 4.81%
% of portfolio
2.11%
Previous 2.32%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$21.87 - $28.24 $284,310 - $367,120
13,000 Added 4.75%
286,936 $7.46 Million
Q4 2023

Feb 13, 2024

BUY
$21.2 - $31.03 $315,880 - $462,347
14,900 Added 5.75%
273,936 $8.38 Million
Q1 2023

May 03, 2023

BUY
$23.68 - $38.51 $900,337 - $1.46 Million
38,021 Added 17.2%
259,036 $6.58 Million
Q4 2022

Feb 02, 2023

BUY
$28.0 - $40.56 $1.28 Million - $1.85 Million
45,622 Added 26.01%
221,015 $8.96 Million
Q2 2022

Jul 28, 2022

SELL
$27.79 - $50.61 $203,533 - $370,667
-7,324 Reduced 4.01%
175,393 $6.18 Million
Q1 2022

May 10, 2022

SELL
$39.62 - $69.97 $858,803 - $1.52 Million
-21,676 Reduced 10.61%
182,717 $8.4 Million
Q4 2021

Feb 09, 2022

BUY
$58.09 - $82.51 $11.9 Million - $16.9 Million
204,393 New
204,393 $13.8 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.11B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Privium Fund Management B.V. Portfolio

Follow Privium Fund Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.